A detailed history of Walleye Capital LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Walleye Capital LLC holds 82,058 shares of OCUL stock, worth $561,276. This represents 0.0% of its overall portfolio holdings.

Number of Shares
82,058
Holding current value
$561,276
% of portfolio
0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$3.85 - $10.93 $315,923 - $896,893
82,058 New
82,058 $746,000
Q2 2023

Aug 14, 2023

BUY
$4.6 - $7.64 $114,328 - $189,884
24,854 Added 132.12%
43,665 $225,000
Q1 2023

May 15, 2023

BUY
$2.79 - $6.27 $52,482 - $117,944
18,811 New
18,811 $99,000
Q2 2022

Aug 08, 2022

SELL
$3.01 - $5.22 $46,600 - $80,816
-15,482 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$4.83 - $7.35 $270,349 - $411,401
-55,973 Reduced 78.33%
15,482 $77,000
Q4 2021

Mar 03, 2022

BUY
$6.16 - $12.07 $440,162 - $862,461
71,455 New
71,455 $498,000
Q3 2020

Nov 16, 2020

SELL
$7.36 - $9.87 $255,392 - $342,489
-34,700 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$4.67 - $8.95 $110,679 - $212,114
23,700 Added 215.45%
34,700 $289,000
Q1 2020

May 15, 2020

BUY
$3.95 - $7.4 $43,450 - $81,400
11,000 New
11,000 $55,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $526M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.